Entheon Biomedical Corp. (CSE:ENBI)

Entheon Biomedical Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 18, 2025	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Market Capitalization	1	1	1	1	2	32
Market Cap Growth	134.54%	17.33%	109.89%	-66.67%	-94.44%	3.86%
Enterprise Value	1	1	1	0	2	28
Last Close Price	0.10	0.10	0.14	0.10	0.30	5.40
PS Ratio	-	-	-	2.36	9.35	-
PB Ratio	6.18	4.49	8.53	1.87	2.88	3.52
P/TBV Ratio	6.18	4.49	8.53	1.87	2.88	10.13
EV/Sales Ratio	-	-	-	0.84	8.04	-
Net Debt / Equity Ratio	-1.19	-0.99	-0.94	-1.09	-1.11	-0.23
Net Debt / EBITDA Ratio	-	-	-	-	0.19	0.25
Net Debt / FCF Ratio	1.04	1.02	0.38	0.96	0.35	0.38
Asset Turnover	-	-	-	0.43	0.04	-
Quick Ratio	4.51	11.10	3.54	4.11	4.67	2.24
Current Ratio	4.67	11.72	4.53	4.64	4.81	3.46
Return on Equity (ROE)	-76.83%	-138.07%	-137.90%	-64.49%	-42.66%	-125.03%
Return on Assets (ROA)	-42.41%	-77.52%	-70.93%	-33.41%	-41.88%	-71.06%
Return on Capital Employed (ROCE)	-128.10%	-103.10%	-228.90%	-99.10%	-585.80%	-90.80%
Earnings Yield	-20.07%	-22.27%	-25.63%	-50.77%	-480.67%	-27.87%
FCF Yield	-	-21.62%	-28.68%	-60.91%	-110.26%	-16.72%
Buyback Yield / Dilution	-67.81%	-73.25%	-30.96%	-	-8.85%	-97.83%

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.